Source: Outsourcing-Pharma

Pivotal: Spanish CRO collaborates with biotech on Asthma clinical trial

Pivotal and Palobiofarma have announced a strategic collaboration to begin a Phase II clinical trial for oral asthma treatment.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Ibrahim Farr's photo - Chairman & CEO of Pivotal SL

Chairman & CEO

Ibrahim Farr

CEO Approval Rating

90/100

Read more